128 related articles for article (PubMed ID: 1799362)
1. Pelvic pain complicating LHRH analogue treatment of fibroids.
Chipato T; Healy DL; Vollenhoven B; Buckler HM
Aust N Z J Obstet Gynaecol; 1991 Nov; 31(4):383-4. PubMed ID: 1799362
[TBL] [Abstract][Full Text] [Related]
2. Shrinkage of uterine fibroids by preoperative LHRH analogue injection.
McClelland HR; Quinn AJ
Ulster Med J; 1992 Apr; 61(1):51-5. PubMed ID: 1535743
[TBL] [Abstract][Full Text] [Related]
3. Clinical predictors for buserelin acetate treatment of uterine fibroids: a prospective study of 40 women.
Vollenhoven BJ; Shekleton P; McDonald J; Healy DL
Fertil Steril; 1990 Dec; 54(6):1032-8. PubMed ID: 2123160
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of patients with uterine fibroids after treatment with the LHRH agonist buserelin.
Matta WH; Shaw RW; Nye M
Br J Obstet Gynaecol; 1989 Feb; 96(2):200-6. PubMed ID: 2495020
[TBL] [Abstract][Full Text] [Related]
5. Shrinkage of a uterine fibroid after subcutaneous infusion of a LHRH agonist.
Healy DL; Fraser HM; Lawson SL
Br Med J (Clin Res Ed); 1984 Nov; 289(6454):1267-8. PubMed ID: 6437510
[No Abstract] [Full Text] [Related]
6. Mechanism of LHRH analogue action in uterine fibroids.
Shaw RW
Horm Res; 1989; 32 Suppl 1():150-3. PubMed ID: 2533145
[TBL] [Abstract][Full Text] [Related]
7. Uterine leiomyoma and LHRH agonist treatment. A preliminary report.
Rolland R; Franssen AM; Willemsen WN; Corbey RS
Prog Clin Biol Res; 1986; 225():313-20. PubMed ID: 3097670
[No Abstract] [Full Text] [Related]
8. Uterine leiomyoma: treatment with LHRH agonist.
Maheux R; Lemay A
Prog Clin Biol Res; 1986; 225():297-311. PubMed ID: 3097669
[No Abstract] [Full Text] [Related]
9. Effects of gonadotrophin-releasing hormone agonist on uterine fibroids and bone density.
Bianchi G; Costantini S; Anserini P; Rovetta G; Monteforte P; Menada MV; FagĂ L; De Cecco L
Maturitas; 1989 Sep; 11(3):179-85. PubMed ID: 2512467
[TBL] [Abstract][Full Text] [Related]
10. The short-term use of luteinising hormone-releasing hormone analogues in uterine fibroids.
Van der Spuy ZM; Fieggan AG; Wood MJ; Pienaar CA
Horm Res; 1989; 32 Suppl 1():137-40. PubMed ID: 2533144
[TBL] [Abstract][Full Text] [Related]
11. Infarcted intramural uterine leiomyomata during buserelin acetate treatment.
Chang MY; Tsai FB; Soong YK
Changgeng Yi Xue Za Zhi; 1993 Jun; 16(2):129-32. PubMed ID: 8339156
[TBL] [Abstract][Full Text] [Related]
12. Toward removing uterine fibroids without surgery: subcutaneous infusion of a luteinizing hormone-releasing hormone agonist commencing in the luteal phase.
Healy DL; Lawson SR; Abbott M; Baird DT; Fraser HM
J Clin Endocrinol Metab; 1986 Sep; 63(3):619-25. PubMed ID: 3090092
[TBL] [Abstract][Full Text] [Related]
13. [GnRH-analogs in the therapy of uterine myomatosis].
Wieacker P; Geisthövel F; Adelberger V; Breckwoldt M
Ther Umsch; 1990 Dec; 47(12):951-7. PubMed ID: 2151405
[TBL] [Abstract][Full Text] [Related]
14. Effect of treatment with LHRH analogue Zoladex on binding of oestradiol, progesterone and epidermal growth factor to uterine fibromyomata.
Baird DT; Bramley TA; Hawkins TA; Lumsden MA; West CP
Horm Res; 1989; 32 Suppl 1():154-6. PubMed ID: 2533146
[TBL] [Abstract][Full Text] [Related]
15. [Shrinkage of uterine leiomyomas after intranasal administration of a LHRH agonist].
Uemura T; Kimura A; Shirasu K; Minaguchi H
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Mar; 41(3):365-8. PubMed ID: 2499643
[No Abstract] [Full Text] [Related]
16. Doppler assessment of uterine blood flow changes in patients with fibroids receiving the gonadotropin-releasing hormone agonist Buserelin.
Matta WH; Stabile I; Shaw RW; Campbell S
Fertil Steril; 1988 Jun; 49(6):1083-5. PubMed ID: 2967195
[TBL] [Abstract][Full Text] [Related]
17. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
Lethaby A; Vollenhoven B; Sowter M
Cochrane Database Syst Rev; 2001; (2):CD000547. PubMed ID: 11405968
[TBL] [Abstract][Full Text] [Related]
18. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
Lethaby A; Vollenhoven B; Sowter M
Cochrane Database Syst Rev; 2000; (2):CD000547. PubMed ID: 10796723
[TBL] [Abstract][Full Text] [Related]
19. [Two cases of hypovolemic shock by massive bleeding associated with submucous leiomyoma during buserelin treatment].
Ueda K; Sawasaki T; Nakaoka Y; Takehara K; Ohama K
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Dec; 45(12):1417-20. PubMed ID: 8270829
[No Abstract] [Full Text] [Related]
20. Zoladex (goserelin) in the treatment of benign gynaecological disorders: an overview of safety and efficacy.
Miller RM; Frank RA
Br J Obstet Gynaecol; 1992 Feb; 99 Suppl 7():37-41. PubMed ID: 1532509
[No Abstract] [Full Text] [Related]
[Next] [New Search]